Company / EPS (Diluted)
Pulmonx Corp EPS (Diluted) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.44
FY2025
5-year range
-$3.16 / -$1.35
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) returned to growth in FY2025 after 2 years of decline, reaching $-1.44.
Based on SEC 10-K filings.
-1.44 in FY2025.
Improved from $-1.59 to $-1.44 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 10.0% year-over-year.
- Peak eps (diluted) was recorded in FY2022.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.44 | +10.0% |
| FY2024 | -$1.60 | -0.6% |
| FY2023 | -$1.59 | -17.8% |
| FY2022 | -$1.35 | +57.3% |
| FY2021 | -$3.16 | +71.4% |
| FY2020 | -$11.03 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026